Trial Profile
Double blind randomized controlled study on the benefit-risk profile of in the treatment of at term or late preterm newborn infants with severe respiratory disorders and pulmonary hypertension
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2014
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2014 New trial record